AUTHORITIES in India have
approved a new policy which will
regulate the prices of more than
650 generic medicines.
The new National Pharmaceutical
Pricing Policy will become effective
in Jul, with drugs classified into
27 therapeutic areas and prices
expected to be cut by 20-25% on
average.
The arrangements will see the
maximum price of each medication
set as the weighted average price of
all variants which have a “volume-based
market share” of over 1%.The above article was sent to subscribers in Pharmacy Daily's issue from 21 May 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 21 May 13
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.